HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 21 filers reported holding HEPION PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $23,000 | -95.9% | 20,479 | -93.3% | 0.00% | -97.3% |
| Q1 2021 | $564,000 | +216.9% | 306,338 | +434.5% | 0.11% | +307.4% |
| Q3 2020 | $178,000 | +39.1% | 57,309 | -21.0% | 0.03% | -49.1% |
| Q1 2020 | $128,000 | -54.0% | 72,575 | -36.9% | 0.05% | -64.7% |
| Q3 2019 | $278,000 | – | 115,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 306,338 | $564,000 | 0.11% |
| PVG ASSET MANAGEMENT CORP | 14,140 | $26,018,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 160,775 | $296,000 | 0.05% |
| Virtu Financial LLC | 179,030 | $329,000 | 0.02% |
| Allen Capital Group, LLC | 23,685 | $44,000 | 0.01% |
| McAdam, LLC | 36,641 | $67,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 10,000 | $18,000 | 0.01% |
| ZEKE CAPITAL ADVISORS, LLC | 50,000 | $92,000 | 0.01% |
| JGP Wealth Management, LLC | 15,000 | $28,000 | 0.01% |
| Onex Canada Asset Management Inc. | 40,000 | $74,000 | 0.00% |